According to two sources who have seen the lab results, China’s CoronaVac, its COVID-19 vaccine, developed by Sinovac Biotech, has a general efficacy of less than 60% in clinical trial in Brazil. Brazil’s Sao Paulo’s Butantan biomedical center, which has… Read More ›
health regulator
Sanofi’s Dengvaxia facing headwinds citing safety concerns
Sanofi has clarified, it has not received any evidence of heightened incidence of severe dengue in vaccinated individuals in real world incidents. Sanofi’s dengue vaccine has got itself into a spot of trouble with the World Health Organization calling for… Read More ›